Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.

Launched by POMERANIAN MEDICAL UNIVERSITY SZCZECIN · Jan 29, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way for cancer patients to monitor their blood counts from home instead of traveling to a hospital. Blood tests are important for patients receiving chemotherapy, as they help doctors ensure the treatment is safe and effective. By allowing patients to check their blood counts at home, the trial aims to reduce unnecessary hospital visits, which can be costly and expose patients to infections. The study involves patients from Denmark, Poland, and Germany, who will use special technology to monitor their blood during and after chemotherapy treatments.

To participate, patients must be at least 18 years old, legally able to consent, and currently receiving chemotherapy for cancer. They should be able to perform simple tasks to collect their blood samples at home. This trial will last for about 12 weeks, including four cycles of chemotherapy, and will include a follow-up period. Participants can expect to learn how to use the home monitoring equipment, and researchers will evaluate how well this approach works and its impact on patients’ lives. Overall, the goal is to make treatment more convenient and improve the quality of life for those undergoing cancer care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • legally competent patients
• • aged 18 or older
• • diagnosed with cancer (ICD-10: C00\* - C97\*)
• • enrolled at the Department of Oncology/Hematology for outpatients
• • participants who are willing and able to give informed consent for participation in the study
• • participants should receive chemotherapy in Daily Chemotherapy Unit and be within 4 weeks of chemotherapy initiation, and the expected duration of chemotherapy should be at least 12 weeks from inclusion
• Exclusion Criteria:
• • inability to give informed consent due to mental capacity or language barrier
• • patient unable or unlikely to be able to perform fine manipulation required to use lancet or cartridge to obtain capillary blood sample and result
• • known bleeding disorder
• • bad circulation preventing the patient from getting enough blood drops to perform the test